Literature DB >> 26905906

Effects of Bariatric Surgery on Outcomes of Patients With Acute Pancreatitis.

Somashekar G Krishna1, Jennifer Behzadi2, Alice Hinton3, Samer El-Dika4, Jeffery R Groce4, Hisham Hussan5, Phil A Hart5, Darwin L Conwell5.   

Abstract

BACKGROUND & AIMS: The prevalence of obesity and number of patients undergoing bariatric surgery are increasing. Obesity has adverse effects in patients with acute pancreatitis (AP). We investigated whether bariatric surgery affects outcomes of patients with AP.
METHODS: We performed a retrospective study, collecting data from the US Nationwide Inpatient Sample (2007-2011) on all adult inpatients (≥18 years) with a principal diagnosis of AP (n = 1,342,681). We compared primary clinical outcomes (mortality, acute kidney injury, and respiratory failure) and secondary outcomes related to healthcare resources (hospital stay and charges) among patient groups using univariate and multivariate analyses. We performed a propensity score-matched analysis to compare outcomes of patients with versus without bariatric surgery.
RESULTS: Of patients admitted to the hospital with a principal diagnosis of AP, 14,332 (1.07%) had undergone bariatric surgery. The number of patients that underwent bariatric surgery doubled, from 1801 in 2007 to 3928 in 2011 (P < .001). AP in patients that had undergone bariatric surgery was most frequently associated with gallstones. Multivariate analysis associated prior bariatric surgery with decreased mortality (odds ratio, 0.41; 95% confidence interval, 0.18-0.92), shorter duration of hospitalization (0.65 days shorter; P < .001), and lower hospital charges ($3558 lower) than in patients with AP not receiving bariatric surgery (P < .001). A propensity score-matched cohort analysis found that mortality and odds of acute kidney injury were similar between patients with versus without history of bariatric surgery, whereas respiratory failure was less frequent in patients who received bariatric surgery (1.34% vs 4.42%; P < .001).
CONCLUSIONS: Prior bariatric surgery in patients hospitalized with AP is not adversely associated with in-hospital mortality, development of organ failure, or healthcare resource use. Bariatric surgery may mitigate the obesity-associated adverse prognostication in AP. These observations are pertinent for future research, because the prevalence of obesity and AP-related hospitalizations is increasing.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute Pancreatitis; Bariatric Surgery; Morbid Obesity; Nationwide Inpatient Sample

Mesh:

Year:  2016        PMID: 26905906     DOI: 10.1016/j.cgh.2016.02.015

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  10 in total

1.  Patterns of Bariatric Surgeries Among U.S. Women Diagnosed with Polycystic Ovarian Syndrome.

Authors:  Hind A Beydoun; May A Beydoun; Sharmin Hossain; Laurel Stadtmauer; Shaker M Eid; Alan B Zonderman
Journal:  J Womens Health (Larchmt)       Date:  2020-02-20       Impact factor: 2.681

2.  The Burden of Systemic Adiposity on Pancreatic Disease: Acute Pancreatitis, Non-Alcoholic Fatty Pancreas Disease, and Pancreatic Cancer.

Authors:  Ahmad Malli; Feng Li; Darwin L Conwell; Zobeida Cruz-Monserrate; Hisham Hussan; Somashekar G Krishna
Journal:  JOP       Date:  2017

3.  Prior Bariatric Surgery Is Linked to Improved Colorectal Cancer Surgery Outcomes and Costs: A Propensity-Matched Analysis.

Authors:  Hisham Hussan; Peter P Stanich; Darrell M Gray; Somashekar G Krishna; Kyle Porter; Darwin L Conwell; Steven K Clinton
Journal:  Obes Surg       Date:  2017-04       Impact factor: 4.129

4.  Effects of Lipolysis-Stimulated Lipoprotein Receptor on Tight Junctions of Pancreatic Ductal Epithelial Cells in Hypertriglyceridemic Acute Pancreatitis.

Authors:  Jie Wang; Mengbin Qin; Qing Wu; Huiying Yang; Biwei Wei; Jinlian Xie; Yingying Qin; Zhihai Liang; Jiean Huang
Journal:  Biomed Res Int       Date:  2022-04-14       Impact factor: 3.246

5.  Class III obesity rather than metabolic syndrome impacts clinical outcomes of acute pancreatitis: A propensity score weighted analysis.

Authors:  Alecia M Blaszczak; Somashekar G Krishna; Phil A Hart; David Bradley; Willa Hsueh; Luis F Lara; Hisham Hussan; Alice Hinton; Darwin L Conwell; Zobeida Cruz-Monserrate
Journal:  Pancreatology       Date:  2020-08-23       Impact factor: 3.996

6.  Weight Loss Surgery Reduces Healthcare Resource Utilization and All-Cause Inpatient Mortality in Morbid Obesity: a Propensity-Matched Analysis.

Authors:  Somashekar G Krishna; Varun Rawal; Claire Durkin; Rohan M Modi; Alice Hinton; Zobeida Cruz-Monserrate; Darwin L Conwell; Hisham Hussan
Journal:  Obes Surg       Date:  2018-10       Impact factor: 4.129

7.  The role of comorbid hypertriglyceridemia and abdominal obesity in the severity of acute pancreatitis: a retrospective study.

Authors:  Xiaoxi Yang; Jiajun He; Shuli Ma; Tingting Wang; Quping Zhu; Fei Cao; Yuanhao Li; Chuting Yang; Chaowu Chen; Guotao Lu; Lianghao Hu; Jun Liu; Weiwei Chen
Journal:  Lipids Health Dis       Date:  2021-11-27       Impact factor: 3.876

8.  Bariatric Surgery Is Associated with a Recent Temporal Increase in Colorectal Cancer Resections, Most Pronounced in Adults Below 50 Years of Age.

Authors:  Hisham Hussan; Arsheya Patel; Samuel Akinyeye; Kyle Porter; Dennis Ahnen; David Lieberman
Journal:  Obes Surg       Date:  2020-08-12       Impact factor: 4.129

9.  A comparison of endoscopic and non-endoscopic biliary intervention outcomes in patients with prior bariatric surgery.

Authors:  Amrit K Kamboj; Victorio Pidlaoan; Mohammad H Shakhatreh; Alice Hinton; Darwin L Conwell; Somashekar G Krishna
Journal:  Endosc Int Open       Date:  2018-01-12

10.  The Type of Bariatric Surgery Impacts the Risk of Acute Pancreatitis: A Nationwide Study.

Authors:  Hisham Hussan; Emmanuel Ugbarugba; Kyle Porter; Sabrena Noria; Bradley Needleman; Steven K Clinton; Darwin L Conwell; Somashekar G Krishna
Journal:  Clin Transl Gastroenterol       Date:  2018-09-12       Impact factor: 4.488

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.